Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain × cabozantinib × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 19 Prostatic Neoplasms 11 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 8 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Pancreatic Neoplasms 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Multiple Myeloma 2 Melanoma 2 Liver Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Medullary 2 Brain Neoplasms 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Pheochromocytoma 1 Paraganglioma, Extra-Adrenal 1 Paraganglioma 1

Interventions

Fentanyl 18 Analgesia 14 Acupuncture Therapy 12 Zoledronic Acid 9 Therapeutics 9 Surveys and Questionnaires 9 Oxycodone 9 nabiximols 8 Morphine 8 Acetaminophen 8 Psychiatric Rehabilitation 7 Ketamine 7 Hydromorphone 7 Lidocaine 6 Ibandronic Acid 6 Radiotherapy 5 Bupivacaine 5 Analgesics, Opioid 5 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Ropivacaine 4 Music Therapy 4 Early Intervention, Educational 4 alvimopan 3 Yoga 3 Tapentadol 3 Radiosurgery 3 Radiofrequency Ablation 3 Methadone 3 Dronabinol 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01605227 2018-03-14

COMET-1

Exelixis

Phase 3 Completed

1,028 enrolled 18 charts

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡